TCGA-55-7913, TCGA-55-7913SENT_1,{},{LUNG,CANCER,MUTATION,PANEL,SPECIMEN,SOURCE,:,LEFT,LOWER,LOBF,l,IING,SPECIMENIBLOCK,NUMBER,EGFR,Mutation,:,NOT,DETECTED,This,result,was,reviewed,and,interpreted,by,The,foilowing,polymorphism,was,detected,:,2361g,>,A.,Sequencing,of,the,entire,coding,region,and,splice,junction,sites,of,exons,18-21,of,the,EGFR,gene,revealed,no,previously,published,mutations,or,any,sequence,changes,that,could,result,in,amino,acid,changes,.},{lung,CANCER,MUTATION,PANEL,SPECIMEN,SOURCE,:,LEFT,LOWER,LOBF,l,IING,SPECIMENIBLOCK,NUMBER,egfr,mutation,:,not,detect,this,result,be,review,and,interpret,by,the,foilowing,polymorphism,be,detect,:,2361g,>,a.,sequencing,of,the,entire,coding,region,and,splice,junction,site,of,exon,18-21,of,the,egfr,gene,reveal,no,previously,publish,mutation,or,any,sequence,change,that,could,result,in,amino,acid,change,.},{NN,NNP,NNP,NNP,NNP,NNP,:,NNP,NNP,NNP,NN,NNP,NNP,NNP,NN,NN,:,NN,VBD,DT,NN,VBD,VBN,CC,VBN,IN,DT,NN,NN,VBD,VBN,:,JJ,JJR,NN,NN,IN,DT,JJ,NN,NN,CC,NN,NN,NNS,IN,NNS,CD,IN,DT,NN,NN,VBD,DT,RB,VBN,NNS,CC,DT,NN,NNS,WDT,MD,VB,IN,NN,NN,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_2,{},{However,,,one,or,more,polymorphic,sequence,changes,were,discovered,in,the,EGFR,gene,.},{however,,,one,or,more,polymorphic,sequence,change,be,discover,in,the,egfr,gene,.},{RB,,,CD,CC,JJR,JJ,NN,NNS,VBD,VBN,IN,DT,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_3,{},{These,polymorphisms,are,interpreted,as,non-pathogenic,because,they,do,not,lead,to,amino,acid,changes,.},{these,polymorphism,be,interpret,as,non-pathogenic,because,they,do,not,lead,to,amino,acid,change,.},{DT,NNS,VBP,VBN,IN,JJ,IN,PRP,VBP,RB,VB,TO,NN,NN,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_4,{},{These,polymorphisms,are,not,expected,to,have,any,clinical,signi?cance,.},{these,polymorphism,be,not,expect,to,have,any,clinical,signi?cance,.},{DT,NNS,VBP,RB,VBN,TO,VB,DT,JJ,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_5,{},{As,7,%,of,patients,who,respond,to,EGFR,inhibitors,do,not,show,mutations,in,exons,18-21,of,EGFR,gene,,,a,negative,resutt,does,not,preclude,the,possibility,of,a,clinical,response,to,EGFR,inhibitors,.},{as,7,%,of,patient,who,respond,to,egfr,inhibitor,do,not,show,mutation,in,exon,18-21,of,egfr,gene,,,a,negative,resutt,do,not,preclude,the,possibility,of,a,clinical,response,to,egfr,inhibitor,.},{IN,CD,NN,IN,NNS,WP,VBP,TO,NN,NNS,VBP,RB,VB,NNS,IN,NNS,CD,IN,NN,NN,,,DT,JJ,NN,VBZ,RB,VB,DT,NN,IN,DT,JJ,NN,TO,NN,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_6,{},{KRAS,Mutation,Analysis,KRAS,Mutation,:,NOT,DETECTED,Based,on,sequence,analysis,,,no,mutations,were,detected,in,K-Ras,exon,1,(,codon,12,&,13,),and,exon,2,(,codon,51,),This,result,was,reviewed,and,interpreted,by,FISH,ALK,.},{KRAS,mutation,analysis,KRAS,mutation,:,not,detect,base,on,sequence,analysis,,,no,mutation,be,detect,in,k-ras,exon,1,(,codon,12,&,13,),and,exon,2,(,codon,51,),this,result,be,review,and,interpret,by,fish,alk,.},{NNP,NN,NN,NNP,NN,:,NN,VBD,VBN,IN,NN,NN,,,DT,NNS,VBD,VBN,IN,JJ,NN,CD,NN,NN,CD,CC,CD,NN,CC,NN,CD,CD,NN,CD,NN,DT,NN,VBD,VBN,CC,VBN,IN,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_7,{},{2923,FISH,,,ALK,.},{2923,fish,,,ALK,.},{CD,NN,,,NNP,.},{}
TCGA-55-7913, TCGA-55-7913SENT_8,{},{ZP23,;,SEE,BELOW,Specimen,Type,:,Paraf?n,Embedded,Tumor,Tissue,Clinical,Indication,:,FISH,study,for,oncology,Method,:,FESH,Total,Cells,:,100,Images,Captured,:,2,RESULT,:},{zp23,;,see,below,Specimen,type,:,Paraf?n,embed,tumor,tissue,clinical,indication,:,fish,study,for,oncology,Method,:,FESH,Total,cell,:,100,image,capture,:,2,result,:},{NN,:,VB,IN,NNP,NN,:,NNP,VBD,NN,NN,JJ,NN,:,NN,NN,IN,JJ,NNP,:,NNP,NNP,NNS,:,CD,NNS,VBN,:,CD,NN,:},{}
TCGA-55-7913, TCGA-55-7913SENT_9,{},{INTERPRETATION,:,FISH,RESULT,NEGATIVE,FOR,REARRANGEMENT,OF,ALK,GENE,,,SUGGESTIVE,OF,GAIN,OF,ALK,REGION,.},{interpretation,:,fish,RESULT,NEGATIVE,for,REARRANGEMENT,of,ALK,GENE,,,SUGGESTIVE,of,GAIN,of,ALK,REGION,.},{NN,:,NN,NNP,NNP,IN,NNP,IN,NNP,NNP,,,NNP,IN,NNP,IN,NNP,NNP,.},{}
TCGA-55-7913, TCGA-55-7913SENT_10,{},{Fluorescence,in,?,situ,hybridization,(,FISH,),analysis,,,using,break-apart,probes,speci?c,for,ALK,gene,(,2p23,;,Abbott,Motecular,),,,did,not,exhibit,a,break,~,apart,pattern,.},{fluorescence,in,?,situ,hybridization,(,fish,),analysis,,,use,break-apart,probe,speci?c,for,alk,gene,(,2p23,;,Abbott,Motecular,),,,do,not,exhibit,a,break,~,apart,pattern,.},{NN,IN,FW,FW,NN,CD,NN,NN,NN,,,VBG,JJ,NNS,VBP,IN,NN,NN,CD,NN,:,NNP,NNP,NN,,,VBD,RB,VB,DT,NN,NN,RB,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_11,{},{Thus,,,this,result,is,not,indicative,of,a,translocation,involving,the,ALK,gene,.},{thus,,,this,result,be,not,indicative,of,a,translocation,involve,the,alk,gene,.},{RB,,,DT,NN,VBZ,RB,JJ,IN,DT,NN,VBG,DT,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_12,{},{As,an,incidental,?nding,,,additional,1-6,copies,ofthe,ALK,region,were,observed,in,79,%,of,cells,.},{as,a,incidental,?nding,,,additional,1-6,copy,ofthe,alk,region,be,observe,in,79,%,of,cell,.},{IN,DT,JJ,NN,,,JJ,JJ,NNS,VBP,NN,NN,VBD,VBN,IN,CD,NN,IN,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_13,{},{This,suggests,gain,of,the,ALK,region,.},{this,suggest,gain,of,the,alk,region,.},{DT,VBZ,NN,IN,DT,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_14,{},{The,clinical,signi?cance,of,this,incidental,?nding,is,unknown,.},{the,clinical,signi?cance,of,this,incidental,?nding,be,unknown,.},{DT,JJ,NN,IN,DT,JJ,NN,VBZ,JJ,.},{}
TCGA-55-7913, TCGA-55-7913SENT_15,{},{A,small,proportion,of,tumors,(,approximately,5,%,),with,ALK,rearrangement,demonstrated,by,other,methods,may,be,missed,by,this,study,.},{a,small,proportion,of,tumor,(,approximately,5,%,),with,alk,rearrangement,demonstrate,by,other,method,may,be,miss,by,this,study,.},{DT,JJ,NN,IN,NNS,CD,RB,CD,NN,CD,IN,NN,NN,VBN,IN,JJ,NNS,MD,VB,VBN,IN,DT,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_16,{},{This,result,does,not,rule,out,a,malignancy,or,other,genetic,changes,.},{this,result,do,not,rule,out,a,malignancy,or,other,genetic,change,.},{DT,NN,VBZ,RB,VB,RP,DT,NN,CC,JJ,JJ,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_17,{},{This,resuit,should,be,considered,in,combination,with,other,clinical,andlor,laboratory,data,.},{this,resuit,should,be,consider,in,combination,with,other,clinical,andlor,laboratory,datum,.},{DT,NN,MD,VB,VBN,IN,NN,IN,JJ,JJ,NN,NN,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_18,{},{The,cutoff,values,for,ALK,rearrangement,are,12,%,for,paraf?n-embedded,specimens,,,3,%,for,bone,marrow,,,5,%,for,peripheral,blood,.},{the,cutoff,value,for,ALK,rearrangement,be,12,%,for,paraf?n-embedded,specimen,,,3,%,for,bone,marrow,,,5,%,for,peripheral,blood,.},{DT,NN,NNS,IN,NNP,NN,VBP,CD,NN,IN,JJ,NNS,,,CD,NN,IN,NN,NN,,,CD,NN,IN,JJ,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_19,{},{Please,expect,the,result,of,any,other,concurrent,test,in,a,separate,report,.},{please,expect,the,result,of,any,other,concurrent,test,in,a,separate,report,.},{VB,VB,DT,NN,IN,DT,JJ,JJ,NN,IN,DT,JJ,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_20,{},{This,test,was,developed,and,its,performance,characteristics,were,determined,by,),_,not,been,cleared,or,approved,by,the,U.S.,Food,and,Drug,Administration,.},{this,test,be,develop,and,its,performance,characteristic,be,determine,by,),_,not,be,clear,or,approve,by,the,U.S.,Food,and,Drug,Administration,.},{DT,NN,VBD,VBN,CC,PRP$,NN,NNS,VBD,VBN,IN,CD,CD,RB,VBN,VBN,CC,VBN,IN,DT,NNP,NNP,CC,NNP,NNP,.},{}
TCGA-55-7913, TCGA-55-7913SENT_21,{},{The,FDA,has,determined,that,such,clearance,or,a,rovalris,not,necessa,l-rerformance,characteristics,refer,to,the,analytical,performance,of,the,test,.},{the,FDA,have,determine,that,such,clearance,or,a,rovalri,not,necessa,l-rerformance,characteristic,refer,to,the,analytical,performance,of,the,test,.},{DT,NNP,VBZ,VBN,IN,JJ,NN,CC,DT,NN,RB,JJ,NN,NNS,VBP,TO,DT,JJ,NN,IN,DT,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_22,{},{Laboratory,results,reviewed,and,Clinical,interpretation,provided,by},{laboratory,result,review,and,clinical,interpretation,provide,by},{NN,VBZ,VBN,CC,JJ,NN,VBN,IN},{}
TCGA-55-7913, TCGA-55-7913SENT_23,{},{Mutational,analysis,ofthe,EGFR,and,KRAS,genes,and,ALK,locus,rearrangement,by,FISH,were,perfonned,to,survey,the,most,common,tumor-associated,genetic,changes,that,have,been,shown,to,have,prognostic,and,therapeutic,consequences,in,non-small,cell,lung,cancer,(,NSCLC,),.},{mutational,analysis,ofthe,egfr,and,kra,gene,and,alk,locus,rearrangement,by,fish,be,perfonn,to,survey,the,most,common,tumor-associated,genetic,change,that,have,be,show,to,have,prognostic,and,therapeutic,consequence,in,non-small,cell,lung,cancer,(,nsclc,),.},{JJ,NN,JJ,NN,CC,NN,NNS,CC,NN,NN,NN,IN,NN,VBD,VBN,TO,VB,DT,RBS,JJ,JJ,JJ,NNS,WDT,VBP,VBN,VBN,TO,VB,JJ,CC,JJ,NNS,IN,JJ,NN,NN,NN,CD,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_24,{},{EGFR,kinase,domain,mutations,are,found,in,10-15,%,of,lung,adenocarcinomas,,,particularly,those,occurring,in,younger,patients,without,a,smoking,history,,,and,identify,tumors,that,may,have,signi?cant,clinical,response,to,EGFR-targeted,kinase,inhibitors,.},{egfr,kinase,domain,mutation,be,find,in,10-15,%,of,lung,adenocarcinoma,,,particularly,those,occur,in,younger,patient,without,a,smoking,history,,,and,identify,tumor,that,may,have,signi?cant,clinical,response,to,egfr-targeted,kinase,inhibitor,.},{NN,NN,NN,NNS,VBP,VBN,IN,CD,NN,IN,NN,NNS,,,RB,DT,VBG,IN,JJR,NNS,IN,DT,NN,NN,,,CC,VB,NNS,WDT,MD,VB,JJ,JJ,NN,TO,JJ,NN,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_25,{},{Secondary,somatic,mutations,in,EGFR,,,particularly,TYQDM,in,exon,20,,,may,accompany,acquired,resistance,to,these,inhibitors,.},{secondary,somatic,mutation,in,egfr,,,particularly,TYQDM,in,exon,20,,,may,accompany,acquire,resistance,to,these,inhibitor,.},{JJ,JJ,NNS,IN,NN,,,RB,NNP,IN,NN,CD,,,MD,VB,VBN,NN,TO,DT,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_26,{},{KRAS,point,mutations,occur,in,20-30,%,of,lung,adenocarcinomas,and,are,largely,mutually,exclusive,with,EGFR,mutations,.},{KRAS,point,mutation,occur,in,20-30,%,of,lung,adenocarcinoma,and,be,largely,mutually,exclusive,with,egfr,mutation,.},{NNP,NN,NNS,VBP,IN,CD,NN,IN,NN,NNS,CC,VBP,RB,RB,JJ,IN,NN,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_27,{},{KRAS,mutations,are,associated,with,a,poor,prognosis,and,resistance,to,anti-EGFR-directed,lmmunotherapy,.},{KRAS,mutation,be,associate,with,a,poor,prognosis,and,resistance,to,anti-egfr-directed,lmmunotherapy,.},{NNP,NNS,VBP,VBN,IN,DT,JJ,NN,CC,NN,TO,JJ,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_28,{},{ALK,locus,rearrangement,resulting,in,the,EML4-ALK,gene,fusion,is,present,in,3-5,%,of,NSCLC,,,is,most,commonly,seen,in,adenocarcinomas,from,younger,patients,,,and,produces,overexpression,of,the,ALK,tyrosine,kinase,.},{alk,locus,rearrangement,result,in,the,eml4-alk,gene,fusion,be,present,in,3-5,%,of,NSCLC,,,be,most,commonly,see,in,adenocarcinoma,from,younger,patient,,,and,produce,overexpression,of,the,ALK,tyrosine,kinase,.},{NN,NN,NN,VBG,IN,DT,NN,NN,NN,VBZ,JJ,IN,CD,NN,IN,NNP,,,VBZ,RBS,RB,VBN,IN,NNS,IN,JJR,NNS,,,CC,VBZ,NN,IN,DT,NNP,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_29,{},{Patients,who,harbor,ALK,rearrangement,do,not,bene?t,from,EGF,R,tyrosine,kinase,inhibitors,and,are,recommended,to,be,directed,to,trials,of,ALK-targeted,agents,.},{patient,who,harbor,alk,rearrangement,do,not,bene?t,from,egf,r,tyrosine,kinase,inhibitor,and,be,recommend,to,be,direct,to,trial,of,alk-targeted,agent,.},{NNS,WP,VBP,NN,NN,VBP,RB,VBN,IN,NN,NN,NN,NN,NNS,CC,VBP,VBN,TO,VB,VBN,TO,NNS,IN,JJ,NNS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_30,{},{The,exons,tested,cumulatively,comprise,greater,than,95,%,of,the,known,activating,mutations,in,the,selected,genes,;,rare,mutations,occurring,at,other,sites,or,in,other,genes,that,may,in?uence,outcome,can,not,be,excluded,.},{the,exon,test,cumulatively,comprise,greater,than,95,%,of,the,known,activating,mutation,in,the,select,gene,;,rare,mutation,occur,at,other,site,or,in,other,gene,that,may,in?uence,outcome,can,not,be,exclude,.},{DT,NNS,VBN,RB,VBP,JJR,IN,CD,NN,IN,DT,JJ,NN,NNS,IN,DT,VBN,NNS,:,JJ,NNS,VBG,IN,JJ,NNS,CC,IN,JJ,NNS,WDT,MD,VB,NN,MD,RB,VB,VBN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_31,{},{Genomic,DNA,was,extracted,from,microdissected,paratlin,?,embedded,tissue,sections,isolated,from,the,submitted,block,.},{genomic,dna,be,extract,from,microdissected,paratlin,?,embedded,tissue,section,isolate,from,the,submit,block,.},{JJ,NN,VBD,VBN,IN,JJ,NN,NN,JJ,NN,NNS,VBN,IN,DT,VBN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_32,{},{PCR-based,DNA,sequencing,was,used,to,assess,for,mutations,in,exon,1,(,including,codon,12,8,.},{pcr-based,dna,sequencing,be,use,to,assess,for,mutation,in,exon,1,(,include,codon,12,8,.},{JJ,NN,NN,VBD,VBN,TO,VB,IN,NNS,IN,NN,CD,CD,VBG,NN,CD,CD,.},{}
TCGA-55-7913, TCGA-55-7913SENT_33,{},{13,),and,exon,2,(,including,codon,61,),of,KRAS,and,exons,18-21,of,the,EGFR,tyrosine,kinase,(,TK,),domain,.},{13,),and,exon,2,(,include,codon,61,),of,KRAS,and,exon,18-21,of,the,egfr,tyrosine,kinase,(,tk,),domain,.},{CD,NN,CC,NN,CD,CD,VBG,NN,CD,NN,IN,NNP,CC,NNS,CD,IN,DT,NN,NN,NN,CD,NN,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_34,{},{The,sensitivity,for,mutation,detection,for,these,assays,is,approximately,10,%,mutant,allele,in,the,background,of,normal,allele,in,the,microdissected,area,.},{the,sensitivity,for,mutation,detection,for,these,assay,be,approximately,10,%,mutant,allele,in,the,background,of,normal,allele,in,the,microdissected,area,.},{DT,NN,IN,NN,NN,IN,DT,NNS,VBZ,RB,CD,NN,JJ,NN,IN,DT,NN,IN,JJ,NN,IN,DT,JJ,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_35,{},{The,KRAS,and,EGFR,test,was,developed,and,its,performance,characteristics,have,been,detennined,by,Capistrano,.},{the,KRAS,and,egfr,test,be,develop,and,its,performance,characteristic,have,be,detennine,by,Capistrano,.},{DT,NNP,CC,NN,NN,VBD,VBN,CC,PRP$,NN,NNS,VBP,VBN,VBN,IN,NNP,.},{}
TCGA-55-7913, TCGA-55-7913SENT_36,{},{Performance,characteristics,refer,to,the,analytical,performance,of,the,test,.},{Performance,characteristic,refer,to,the,analytical,performance,of,the,test,.},{NNP,NNS,VBP,TO,DT,JJ,NN,IN,DT,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_37,{},{The,FISH,test,was,developed,and,its,perfomtance,characteristics,have,been,determined,by,It,has,not,been,cleared,or,approved,by,the,U.S.,Food,and,Drug,Administration,.},{the,fish,test,be,develop,and,its,perfomtance,characteristic,have,be,determine,by,it,have,not,be,clear,or,approve,by,the,U.S.,Food,and,Drug,Administration,.},{DT,NN,NN,VBD,VBN,CC,PRP$,NN,NNS,VBP,VBN,VBN,IN,PRP,VBZ,RB,VBN,VBN,CC,VBN,IN,DT,NNP,NNP,CC,NNP,NNP,.},{}
TCGA-55-7913, TCGA-55-7913SENT_38,{},{The,FDA,has,determined,that,such,clearance,oriapproval,is,not,necessary,.},{the,FDA,have,determine,that,such,clearance,oriapproval,be,not,necessary,.},{DT,NNP,VBZ,VBN,IN,JJ,NN,NN,VBZ,RB,JJ,.},{}
TCGA-55-7913, TCGA-55-7913SENT_39,{},{Performance,characteristics,refer,to,the,analytical,perfonnance,ofthe,test,.},{Performance,characteristic,refer,to,the,analytical,perfonnance,ofthe,test,.},{NNP,NNS,VBP,TO,DT,JJ,NN,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_40,{},{Test,performed,at,I},{test,perform,at,I},{NN,VBN,IN,PRP},{}
TCGA-55-7913, TCGA-55-7913SENT_41,{},{Addendum,Report,Issued,By,:},{Addendum,Report,issue,by,:},{NNP,NNP,VBD,IN,:},{}
TCGA-55-7913, TCGA-55-7913SENT_42,{},{DIAGNOSIS,:,A.,Left,lower,lobe,lung,,,lobectomy,:,Tumor,Characteristics,:,1,.},{diagnosis,:,a.,leave,lower,lobe,lung,,,lobectomy,:,tumor,characteristic,:,1,.},{NN,:,NN,VBD,JJR,NN,NN,,,NN,:,NN,NNS,:,CD,.},{}
TCGA-55-7913, TCGA-55-7913SENT_43,{},{Histologic,type,:,Adenocarcinoma,.},{histologic,type,:,adenocarcinoma,.},{JJ,NN,:,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_44,{},{2,.},{2,.},{LS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_45,{},{Histologic,grade,:,Well,differentiated,with,focal,mucin,production,.},{histologic,grade,:,well,differentiate,with,focal,mucin,production,.},{JJ,NN,:,UH,VBN,IN,JJ,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_46,{},{3,.},{3,.},{LS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_47,{},{Tumor,site,:,Left,lower,lobe,lung,.},{tumor,site,:,leave,lower,lobe,lung,.},{NN,NN,:,VBN,JJR,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_48,{},{Tumor,focality,:,Unifocal,.},{tumor,focality,:,Unifocal,.},{NN,NN,:,NNP,.},{}
TCGA-55-7913, TCGA-55-7913SENT_49,{},{Tumor,size,:,2.8,x,2.7,x,2.4,cm,.},{tumor,size,:,2.8,x,2.7,x,2.4,cm,.},{NN,NN,:,CD,CC,CD,CC,CD,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_50,{},{Visceral,pleural,invasion,:,No.,.},{visceral,pleural,invasion,:,no.,.},{JJ,JJ,NN,:,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_51,{},{Lymphovascular,space,invasion,:,No.,.},{lymphovascular,space,invasion,:,no.,.},{JJ,NN,NN,:,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_52,{},{Tumor,extension,:,Con?ned,to,the,left,lower,lobe,.},{tumor,extension,:,con?ned,to,the,leave,lower,lobe,.},{NN,NN,:,VBN,TO,DT,VBN,JJR,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_53,{},{.0,?,.},{.0,?,.},{NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_54,{},{?,4F5,?,.},{?,4f5,?,.},{NN,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_55,{},{U,",.},{U,",.},{NNP,``,.},{}
TCGA-55-7913, TCGA-55-7913SENT_56,{},{-,l,?},{-,l,?},{:,NN,CD},{}
TCGA-55-7913, TCGA-55-7913SENT_57,{},{Surgical,Margin,Status,:},{Surgical,margin,Status,:},{NNP,NN,NNP,:},{}
TCGA-55-7913, TCGA-55-7913SENT_58,{},{1,.},{1,.},{LS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_59,{},{Tumor,distance,from,bronchial,margin,:,o.,?},{tumor,distance,from,bronchial,margin,:,o.,?},{NN,NN,IN,JJ,NN,:,VB,.},{}
TCGA-55-7913, TCGA-55-7913SENT_60,{},{?,cm,.},{?,cm,.},{NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_61,{},{2,.},{2,.},{LS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_62,{},{Tumor,distance,from,parenchymal,(,stapled,),margin,:,0.5,cm,.},{tumor,distance,from,parenchymal,(,staple,),margin,:,0.5,cm,.},{NN,NN,IN,JJ,NN,VBD,CD,NN,:,CD,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_63,{},{3,.},{3,.},{LS,.},{}
TCGA-55-7913, TCGA-55-7913SENT_64,{},{Tumor,distance,from,pleural,surface,:,Adjacent,to,though,does,not,involve,the,pleura,.},{tumor,distance,from,pleural,surface,:,adjacent,to,though,do,not,involve,the,pleuron,.},{NN,NN,IN,JJ,NN,:,JJ,TO,RB,VBZ,RB,VB,DT,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_65,{},{TNM,:,pT1b},{TNM,:,pt1b},{NNP,:,NN},{}
TCGA-55-7913, TCGA-55-7913SENT_66,{},{13,.},{13,.},{CD,.},{}
TCGA-55-7913, TCGA-55-7913SENT_67,{},{Level,5,lymph,node,,,biopsies,:},{level,5,lymph,node,,,biopsy,:},{NN,CD,NN,NN,,,NNS,:},{}
TCGA-55-7913, TCGA-55-7913SENT_68,{},{Single,node,negative,for,malignancy,(,011,),.},{single,node,negative,for,malignancy,(,011,),.},{JJ,NN,JJ,IN,NN,NN,CD,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_69,{},{O.,Level,15,lymph,node,.},{O.,Level,15,lymph,node,.},{NNP,NNP,CD,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_70,{},{biopsy,:},{biopsy,:},{NN,:},{}
TCGA-55-7913, TCGA-55-7913SENT_71,{},{Sinolelymph,node,nesativeformalignancy,(,OH,),.},{sinolelymph,node,nesativeformalignancy,(,oh,),.},{JJ,NN,NN,CD,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_72,{},{Y,*,_,Y,*,Y,*,__,__,@,Y,*,__,.},{y,*,_,y,*,y,*,__,__,@,y,*,__,.},{NN,CD,CD,NN,CD,NN,CD,CD,NN,IN,NN,CD,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_73,{},{.},{.},{.},{}
TCGA-55-7913, TCGA-55-7913SENT_74,{},{_,...,:,_,c,_,:,.},{_,...,:,_,c,_,:,.},{NN,:,:,CD,NN,NN,:,.},{}
TCGA-55-7913, TCGA-55-7913SENT_75,{},{s.,$,.},{s.,$,.},{RB,$,.},{}
TCGA-55-7913, TCGA-55-7913SENT_76,{},{.},{.},{.},{}
TCGA-55-7913, TCGA-55-7913SENT_77,{},{-,L.,.},{-,l.,.},{:,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_78,{},{.},{.},{.},{}
TCGA-55-7913, TCGA-55-7913SENT_79,{},{_,.},{_,.},{NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_80,{},{COMMENTS,:,TTF1,by,immunoperoxidase,is,positive,consistent,with,a,lung,primary,.},{comment,:,ttf1,by,immunoperoxidase,be,positive,consistent,with,a,lung,primary,.},{NNS,:,NN,IN,NN,VBZ,JJ,JJ,IN,DT,NN,JJ,.},{}
TCGA-55-7913, TCGA-55-7913SENT_81,{},{Ancillary,studies,(,CLINICAL,HISTORY,:,Preoperative,Diagnosis,Postoperative,Diagnosi,SymptomsfRadiologic,Findings,:,SPECIMENS,:,A.,Left,lower,lobe,lung,B.,Level,9,lymph,node,C.,Level5lymph,node},{ancillary,study,(,clinical,history,:,Preoperative,diagnosis,postoperative,diagnosus,symptomsfradiologic,finding,:,specimen,:,a.,leave,lower,lobe,lung,B.,Level,9,lymph,node,C.,Level5lymph,node},{JJ,NNS,VBP,JJ,NN,:,NNP,NN,JJ,NN,JJ,NNS,:,NNS,:,NN,VBD,JJR,NN,NN,NNP,NNP,CD,NN,NN,NNP,NNP,NN},{}
TCGA-55-7913, TCGA-55-7913SENT_82,{},{B.,Container,B,is,labeled,,,le,vel,9,lymph,node,.},{B.,Container,b,be,label,,,le,vel,9,lymph,node,.},{NNP,NNP,NN,VBZ,VBN,,,DT,NN,CD,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_83,{},{Received,in,formalin,is,a,1.7,x,1.0,X,0.5,cm,anthracotic,lymph,node,.},{receive,in,formalin,be,a,1.7,x,1.0,x,0.5,cm,anthracotic,lymph,node,.},{VBN,IN,NN,VBZ,DT,CD,CC,CD,NN,CD,NN,JJ,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_84,{},{The,entire,specimen,is,sectioned,and,submitted,in,cassette,B1,labeled,C.,Container,C,is,labeled,,,level,5,lymph,node,.},{the,entire,specimen,be,section,and,submit,in,cassette,b1,label,C.,Container,C,be,label,,,level,5,lymph,node,.},{DT,JJ,NN,VBZ,VBN,CC,VBN,IN,NN,NN,VBN,NNP,NNP,NNP,VBZ,VBN,,,NN,CD,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_85,{},{Received,in,formalin,is,a,1.2,x,0.8,x,0.6,cm,red-tan,lymph,node,.},{receive,in,formalin,be,a,1.2,x,0.8,x,0.6,cm,red-tan,lymph,node,.},{VBN,IN,NN,VBZ,DT,CD,CC,CD,CC,CD,NN,NN,NN,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_86,{},{The,lymph,node,is,trisecled,and,i,cassette,C1,labeled},{the,lymph,node,be,trisecle,and,i,cassette,c1,label},{DT,NN,NN,VBZ,VBN,CC,FW,NN,NN,VBN},{}
TCGA-55-7913, TCGA-55-7913SENT_87,{},{A.,Ad_ditio,__,n_als_ections,01,:,tyg3_qH,pleura,are,submitted,in,casse_ttes,,1,_,?,l_S9,/,~,_,A1/Zylgla/elfe,?},{a.,Ad_ditio,__,n_als_ections,01,:,tyg3_qh,pleuron,be,submit,in,casse_ttes,,1,_,?,l_s9,/,~,_,a1/zylgla/elfe,?},{NN,NNP,CD,NNS,CD,:,NN,NN,VBP,VBN,IN,NNS,CD,CD,CD,NN,:,CD,CD,NN,NN},{}
TCGA-55-7913, TCGA-55-7913SENT_88,{},{_,.},{_,.},{NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_89,{},{o,*,@,*,Y,*,/,.},{o,*,@,*,y,*,/,.},{NN,CD,SYM,CD,NN,CD,:,.},{}
TCGA-55-7913, TCGA-55-7913SENT_90,{},{_,M,__,-,_,.},{_,m,__,-,_,.},{CD,NN,SYM,:,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_91,{},{__,-,.},{__,-,.},{SYM,:,.},{}
TCGA-55-7913, TCGA-55-7913SENT_92,{},{_,.},{_,.},{NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_93,{},{__,.},{__,.},{NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_94,{},{.},{.},{.},{}
TCGA-55-7913, TCGA-55-7913SENT_95,{},{a,_,.},{a,_,.},{DT,NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_96,{},{,,-,,,?,,,-,.},{,,-,,,?,,,-,.},{,,:,,,NN,,,:,.},{}
TCGA-55-7913, TCGA-55-7913SENT_97,{},{__,.},{__,.},{NN,.},{}
TCGA-55-7913, TCGA-55-7913SENT_98,{},{_,@,*},{_,@,*},{NN,SYM,SYM},{}
